Clinical Trial Update: A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports that a Phase 2 study is evaluating ketamine infusions to treat depression in ICU patients, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Mayo Clinic | Conditions: Depression | Phase 2 | Status: RECRUITING